EDITORIALS

Functional Imaging in Phase I Studies: Decorations or Decision Making?

Jerry M. Collins

JCO Aug 1 2003: 2807–2809. First published on Jun 13 2003; 10.1200/JCO.2003.05.100. [Full Text] [PDF]

Dose-Intense Paclitaxel: Déjà Vu All Over Again?

Chris H. Takimoto and Eric K. Rowinsky

JCO Aug 1 2003: 2810–2814. First published on Jun 13 2003; 10.1200/JCO.2003.05.099. [Full Text] [PDF]

ORIGINAL REPORTS
Phase I and Clinical Pharmacology
	Phase I Clinical Trial of Weekly Combretastatin A4 Phosphate: Clinical and Pharmacokinetic Results
	Gordon J.S. Rustin, Susan M. Galbraith, Helen Anderson, Michael Stratford, Lisa K. Folkes, Luiza Sena, Lindsey Gumbrell, and Patricia M. Price
	JCO Aug 1 2003: 2815–2822. First published on Jun 13 2003; 10.1200/JCO.2003.05.185. [Abstract] [Full Text] [PDF]
	Assessment of Pharmacodynamic Vascular Response in a Phase I Trial of Combretastatin A4 Phosphate
	Helen L. Anderson, Jeffrey T. Yap, Mathew P. Miller, Adele Robbins, Terry Jones, and Patricia M. Price
	JCO Aug 1 2003: 2823–2830. First published on Jun 13 2003; 10.1200/JCO.2003.05.186. [Abstract] [Full Text] [PDF]
	Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance Imaging
	Susan M. Galbraith, Ross J. Maxwell, Martin A. Lodge, Gillian M. Tozer, John Wilson, N. Jane Taylor, J. James Stirling, Luiza Sena, Anwar R. Padhani, and Gordon J.S. Rustin
	JCO Aug 1 2003: 2831–2842. First published on Jun 13 2003; 10.1200/JCO.2003.05.187. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Phase III Trial of Paclitaxel at Two Dose Levels, the Higher Dose Accompanied by Filgrastim at Two Dose Levels in Platinum-Pretreated Epithelial Ovarian Cancer: An Intergroup Study
	George A. Omura, Mark F. Brady, Katherine Y. Look, Hervy E. Averette, James E. Delmore, Harry J. Long, Scott Wadler, Gregory Spiegel, and Susan G. Arbuck
	JCO Aug 1 2003: 2843–2848. First published on Jun 13 2003; 10.1200/JCO.2003.10.082. [Abstract] [Full Text] [PDF]
	Intraperitoneal Radioactive Phosphorus (32P) Versus Observation After Negative Second-Look Laparotomy for Stage III Ovarian Carcinoma: A Randomized Trial of the Gynecologic Oncology Group
	Mahesh A. Varia, Frederick B. Stehman, Brian N. Bundy, Jo Ann Benda, Daniel L. Clarke-Pearson, Ronald D. Alvarez, and Harry J. Long
	JCO Aug 1 2003: 2849–2855. [Abstract] [Full Text] [PDF]
	Phase II Study of Oxaliplatin in Platinum-Resistant and Refractory Ovarian Cancer: A Gynecologic Group Study
	Paula M. Fracasso, John A. Blessing, Mark A. Morgan, Anil K. Sood, and James S. Hoffman
	JCO Aug 1 2003: 2856–2859. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Prognostic Significance of Visible Lesions on Transrectal Ultrasound in Impalpable Prostate Cancers: Implications for Staging
	Herbert Augustin, Markus Graefen, Jüri Palisaar, Jakob Blonski, Andreas Erbersdobler, Fedor Daghofer, Hartwig Huland, and Peter G. Hammerer
	JCO Aug 1 2003: 2860–2868. [Abstract] [Full Text] [PDF]
	Repeated Bone-Targeted Therapy for Hormone-Refractory Prostate Carcinoma: Randomized Phase II Trial With the New, High-Energy Radiopharmaceutical Rhenium-188 Hydroxyethylidenediphosphonate
	Holger Palmedo, Agnieska Manka-Waluch, Peter Albers, Ingo G.H. Schmidt-Wolf, Michael Reinhardt, Samer Ezziddin, Alexius Joe, Roland Roedel, Rolf Fimmers, F.F. Knapp, Jr, Stefan Guhlke, and Hans-Jürgen Biersack
	JCO Aug 1 2003: 2869–2875. [Abstract] [Full Text] [PDF]

AIDS Related Cancer
	AIDS-Related Kaposi’s Sarcoma: Evaluation of Potential New Prognostic Factors and Assessment of the AIDS Clinical Trial Group Staging System in the Haart Era—the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naïve From Antiretrovirals
	Guglielmo Nasti, Renato Talamini, Andrea Antinori, Ferdinando Martellotta, Gaia Jacchetti, Francesco Chiodo, Giuseppe Ballardini, Laura Stoppini, Giovanni Di Perri, Maurizio Mena, Marcello Tavio, Emanuela Vaccher, Antonella D’Arminio Monforte, and Umberto Tirelli
	JCO Aug 1 2003: 2876–2882. [Abstract] [Full Text] [PDF]

Melanoma
	Prospective Randomized Trial of Interferon Alfa-2b and Interleukin-2 as Adjuvant Treatment for Resected Intermediate- and High-Risk Primary Melanoma Without Clinically Detectable Node Metastasis
	Axel Hauschild, Michael Weichenthal, Bernd-Rüdiger Balda, Jürgen C. Becker, Helmut H. Wolff, Wolfgang Tilgen, Klaus-Werner Schulte, Johannes Ring, Dirk Schadendorf, Stephan Lischner, Günter Burg, and Reinhard Dummer
	JCO Aug 1 2003: 2883–2888. [Abstract] [Full Text] [PDF]

Breast Cancer
	Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm
	Harold J. Burstein, Lyndsay N. Harris, P. Kelly Marcom, Rosemary Lambert-Falls, Kathleen Havlin, Beth Overmoyer, Robert J. Friedlander, Jr., Janet Gargiulo, Rochelle Strenger, Charles L. Vogel, Paula D. Ryan, Mathew J. Ellis, Raquel A. Nunes, Craig A. Bunnell, Susana M. Campos, Michele Hallor, Rebecca Gelman, and Eric P. Winer
	JCO Aug 1 2003: 2889–2895. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial
	Thierry André, Philippe Colin, Christophe Louvet, Erik Gamelin, Olivier Bouche, Emmanuel Achille, Nicolas Colbert, Catherine Boaziz, Pascal Piedbois, Nicole Tubiana-Mathieu, Arnaud Boutan-Laroze, Michel Flesch, Marc Buyse, and Aimery de Gramont
	JCO Aug 1 2003: 2896–2903. [Abstract] [Full Text] [PDF]
	Safety and Toxicity Analysis of Oxaliplatin Combined With Fluorouracil or as a Single Agent in Patients With Previously Treated Advanced Colorectal Cancer
	Ramesh K. Ramanathan, Jeffery W. Clark, Nancy E. Kemeny, Heinz-Josef Lenz, Kim O. Gococo, Daniel G. Haller, Edith P. Mitchell, and Carl G. Kardinal
	JCO Aug 1 2003: 2904–2911. [Abstract] [Full Text] [PDF]
	Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089
	T.E. Le Voyer, E.R. Sigurdson, A.L. Hanlon, R.J. Mayer, J.S. Macdonald, P.J. Catalano, and D.G. Haller
	JCO Aug 1 2003: 2912–2919. [Abstract] [Full Text] [PDF]
	Phase II Study of Gemcitabine, Cisplatin, and Infusional Fluorouracil in Advanced Pancreatic Cancer
	B.F. El-Rayes, M.M. Zalupski, A.F. Shields, U. Vaishampayan, L.K. Heilbrun, V. Jain, V. Adsay, J. Day, and P.A. Philip
	JCO Aug 1 2003: 2920–2925. [Abstract] [Full Text] [PDF]
	Phase I Trial of Escalating-Dose Irinotecan Given Weekly With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Cancer
	David H. Ilson, Manjit Bains, David P. Kelsen, Eileen O’Reilly, Martin Karpeh, Daniel Coit, Valerie Rusch, Mithat Gonen, Katie Wilson, and Bruce D. Minsky
	JCO Aug 1 2003: 2926–2932. [Abstract] [Full Text] [PDF]

Lung Cancer
	Multicenter, Randomized Trial for Stage IIIB or IV Non–Small-Cell Lung Cancer Using Weekly Paclitaxel and Carboplatin Followed by Maintenance Weekly Paclitaxel or Observation
	Chandra P. Belani, John Barstis, Michael C. Perry, Renato V. La Rocca, Sreenivasa R. Nattam, David Rinaldi, Ray Clark, and Glenn M. Mills
	JCO Aug 1 2003: 2933–2939. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Mitoxantrone and Cytarabine Induction, High-Dose Cytarabine, and Etoposide Intensification for Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia: Children’s Cancer Group Study 2951
	Robert J. Wells, Mary T. Adams, Todd A. Alonzo, Robert J. Arceci, Jonathan Buckley, Allen B. Buxton, Kathryn Dusenbery, Alan Gamis, Margaret Masterson, Terry Vik, Phyllis Warkentin, and James A. Whitlock
	JCO Aug 1 2003: 2940–2947. [Abstract] [Full Text] [PDF]
	Lymphocyte-Predominant Hodgkin’s Lymphoma in Children: Therapeutic Abstention After Initial Lymph Node Resection—A Study of the French Society of Pediatric Oncology
	B. Pellegrino, M.J. Terrier-Lacombe, O. Oberlin, T. Leblanc, Y. Perel, Y. Bertrand, C. Beard, C. Edan, C. Schmitt, D. Plantaz, H. Pacquement, J.P. Vannier, C. Lambilliote, G. Couillault, A. Babin-Boilletot, I. Thuret, F. Demeocq, G. Leverger, G. Delsol, and J. Landman-Parker
	JCO Aug 1 2003: 2948–2952. [Abstract] [Full Text] [PDF]
	Height and Weight in Children Treated for Acute Lymphoblastic Leukemia: Relationship to CNS Treatment
	Virginia Kimball Dalton, Montse Rue, Lewis B. Silverman, Richard D. Gelber, Barbara L. Asselin, Ronald D. Barr, Luis A. Clavell, Craig A. Hurwitz, Albert Moghrabi, Yvan Samson, Marshall Schorin, Nancy J. Tarbell, Stephen E. Sallan, and Laurie E. Cohen
	JCO Aug 1 2003: 2953–2960. [Abstract] [Full Text] [PDF]
	Cognitive Outcome of Long-Term Survivors of Multisystem Langerhans Cell Histiocytosis: A Single-Institution, Cross-Sectional Study
	Vasanta Rao Nanduri, Leasha Lillywhite, Claire Chapman, Louise Parry, Jon Pritchard, and Faraneh Vargha-Khadem
	JCO Aug 1 2003: 2961–2967. [Abstract] [Full Text] [PDF]
	Study of the MIB-1 Labeling Index as a Predictor of Tumor Progression in Pilocytic Astrocytomas in Children and Adolescents
	Daniel C. Bowers, Lynn Gargan, Payal Kapur, Joan S. Reisch, Arlynn F. Mulne, Kenneth N. Shapiro, Roy D. Elterman, Naomi J. Winick, and Linda R. Margraf
	JCO Aug 1 2003: 2968–2973. [Abstract] [Full Text] [PDF]
	Single Center Experience of a New Intensive Induction Therapy for Ewing’s Family of Tumors: Feasibility, Toxicity, and Stem Cell Mobilization Properties
	S.J. Strauss, A. McTiernan, D. Driver, M. Hall-Craggs, A. Sandison, A.M. Cassoni, A. Kilby, M. Michelagnoli, J. Pringle, J. Cobb, T. Briggs, S. Cannon, J. Witt, and J.S. Whelan
	JCO Aug 1 2003: 2974–2981. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Health-Related Quality of Life in Non–Small-Cell Lung Cancer: Methodologic Issues in Randomized Controlled Trials
	Andrew Bottomley, Fabio Efficace, Ronald Thomas, Veerle Vanvoorden, and Sam H. Ahmedzai
	JCO Aug 1 2003: 2982–2992. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Uncommon Presentations of Malignancies: CASE 1. EXTRAOCULAR MUSCLE PALSIES IN SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA

Gregory D. Leonard, Upendra Hegde, John Butman, Elaine S. Jaffe, and Wyndham H. Wilson

JCO Aug 1 2003: 2993–2995. [Full Text] [PDF]

Uncommon Presentations of Malignancies: CASE 2. CARCINOID TUMOR PRESENTING WITH BONE MARROW METASTASES

Thein H. Oo, Leo S. Aish, Douglas Schneider, and Hani Hassoun

JCO Aug 1 2003: 2995–2996. [Full Text] [PDF]

Uncommon Presentations of Malignancies: CASE 3. BRAIN METASTASIS FROM OVARIAN CANCER

David Atallah, Georges Chahine, and Ioannis A. Voutsadakis

JCO Aug 1 2003: 2996–2998. [Full Text] [PDF]

Uncommon Presentations of Malignancies: CASE 4. TUMOR IMPLANTATION AFTER PNEUMONECTOMY FOR LUNG CANCER

Vinay Raja and David Bessman

JCO Aug 1 2003: 2998–2999. [Full Text] [PDF]

ART OF ONCOLOGY

Allowing Patients to Die: Practical, Ethical, and Religious Concerns

Marc J. Kahn, Cathy J. Lazarus, and Donald P. Owens

JCO Aug 1 2003: 3000–3002. [Full Text] [PDF]

SPECIAL DEPARTMENTS

Correspondence

Alternatives to Cystectomy in Muscle-Invasive Bladder Cancer

Sanjay Goel

JCO Aug 1 2003: 3003. [Full Text] [PDF]

In Reply:

Claus Rödel and Martin Meyer

JCO Aug 1 2003: 3003-a–3004. [Full Text] [PDF]

Morphologic Dysplasia in Acute Myeloid Leukemia: Importance of Granulocytic Dysplasia

John M. Bennett

JCO Aug 1 2003: 3004. [Full Text] [PDF]

In Reply:

Torsten Haferlach, Wolfgang Kern, Claudia Schoch, Wolfgang Hiddemann, and Maria Cristina Sauerland

JCO Aug 1 2003: 3004-a–3005. [Full Text] [PDF]

Opioid Switching

Martin Weber

JCO Aug 1 2003: 3005. [Full Text] [PDF]

In Reply:

Rose Anne Indelicato and Russell K. Portenoy

JCO Aug 1 2003: 3005-a. [Full Text] [PDF]

Errata

ERRATUM

JCO Aug 1 2003: 3006. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.